Thymoglobulin induction and steroid avoidance in cardiac transplantation: Results of a prospective, randomized, controlled study

Clinical Transplantation

Volumn 22, Issue 1, 2008, Pages 76-81

  Yamani, Mohamad H ^a   Taylor, David O ^a   Czerr, Jennifer ^b   Haire, Christinna ^a   Kring, Richard ^b   Zhou, Lingmei ^b   Hobbs, Robert ^a   Smedira, Nicholas ^b   Starling, Randall C ^a  

^a Cardiovascular Medicine   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiac Transplantation; Corticosteroids; Thymoglobulin

Indexed keywords

ACICLOVIR; ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CARBONATE; CLOTRIMAZOLE; CORTICOSTEROID; COTRIMOXAZOLE; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PRAVASTATIN; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR; VITAMIN D;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GRAFT INFECTION; HEART FAILURE; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; INCIDENCE; LEUKOPENIA; LONG TERM CARE; LYMPHOPROLIFERATIVE DISEASE; MALE; MALIGNANT NEOPLASTIC DISEASE; MONOTHERAPY; MUSCLE STRENGTH; OPEN STUDY; OPPORTUNISTIC INFECTION; OSTEOLYSIS; OUTCOME ASSESSMENT; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE DRUG DOSE; SKIN CANCER; THROMBOCYTOPENIA;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBODIES, MONOCLONAL; BONE DENSITY; FEMALE; GLUCOCORTICOIDS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PREDNISONE; PROSPECTIVE STUDIES; PULSE THERAPY, DRUG; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 38549103672     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00748.x     Document Type: Article

References (19)

1. Lerut JP. Avoiding steroids in solid organ transplantation. Transpl Int 2003: 16: 213.
2. Goddard S, Adams DH. Methylprednisolone therapy for acute rejection: Too much of a good thing? Liver Transpl 2002: 8: 535.
3. Meier-K riesche HU, Li S, Gruessner RW et al. Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant 2006: 6: 1111.
4. Cantarovich D, Karam G, Hourmant M et al. Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation. Am J Transplant 2005: 5: 1332.
5. Eason JD, Nair S, Cohen AJ, Blazek JL, Loss GE Jr. Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy. Transplantation 2003: 75: 1396.
6. Rajab A, Pelletier RP, Henry ML, Ferguson RM. Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression. Clin Transplant 2006: 20: 537.
7. Starzl T. A toleragenic strategy for organ transplantation. Transplantation 2002: 74: 147.
8. Renlund D, O'Connell B, Gilbert E. Feasibility of discontinuation of corticosteroid maintenance therapy in heart transplantation. J Heart Lung Transplant 1987: 6: 71.
9. Yacoub M, Alizizatos P. The use of cyclosporine, azathioprine, and antithymocycte globulin with or without low-dose steroids for immunosuppression of cardiac transplant patients. Transplant Proc 1985: 17: 221.
10. Pritzker MR, Lake KD, Reutzel TJ et al. Steroid-free maintenance immunotherapy: Minneapolis Heart Institute experience. J Heart Lung Transplant 1992: 11: 415.
11. Freise CE, Kang SM, Feng S, Hirose R, Stock P. Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation. Arch Surg 2003: 138: 1121.
12. F reise CE, K ang SM, F eng S et al. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation. Transplant Proc 2004: 36: 1067.
13. Matas AJ, Ramcharan T, Paraskevas S et al. Rapid discontinuation of steroids in living donor kidney transplantation: A pilot study. Am J Transplant 2001: 1: 278.
14. K aufman D, L eventhal J, K offron A et al. A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation: Comparison of two maintenance immunosuppression protocols: Tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Transplantation 2002: 73: 169.
15. Katz MR, Barnhart GR, Szentpetery S et al. Are steroids essential for successful maintenance of immunosuppression in heart transplantation? J Heart Transplant 1987: 6: 293.
16. Livi U, Luciani GB, Boffa GM et al. Clinical results of steroid-free induction immunosuppression after heart transplantation. Ann Thorac Surg 1993: 55: 1160.
17. Taylor DO, Bristow MR, O'Connell JB et al. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy. J Heart Lung Transplant 1996: 15: 1039.
18. Kobashigawa JA, Leaf DA, Lee N et al. A controlled trial of exercise rehabilitation after heart transplantation. N Engl J Med 1999: 340: 272.
19. Carrier M, White M, Perrault LP et al. A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation. J Heart Lung Transplant 1999: 18: 1218.